Comparison
Abducens Nerve Neoplasm C1263898 vs 17q11 2 Microduplication Syndrome C3495679
Clinical comparison between Abducens Nerve Neoplasm and 17q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
Abducens Nerve Neoplasm C1263898
A tumor of the 6th cranial nerve that controls eye movement. Can affect anyone. Treated with surgery or radiation.
17q11 2 Microduplication Syndrome C3495679
A genetic disorder caused by duplication of a segment on chromosome 17. Individuals may have developmental delays, behavioral concerns, and physical features. Treatment focuses on early intervention.
6 comparison axes
Onset
Abducens Nerve Neoplasm C1263898
Variable
17q11 2 Microduplication Syndrome C3495679
0-null
Onset patterns differ
Severity
Abducens Nerve Neoplasm C1263898
severe
17q11 2 Microduplication Syndrome C3495679
moderate
Different severity levels
Chronic
Abducens Nerve Neoplasm C1263898
Chronic
17q11 2 Microduplication Syndrome C3495679
Chronic
Differing course
Communicable
Abducens Nerve Neoplasm C1263898
No
17q11 2 Microduplication Syndrome C3495679
No
Different transmission
Body System
Abducens Nerve Neoplasm C1263898
neurologic
17q11 2 Microduplication Syndrome C3495679
congenital
Same/different system
Category
Abducens Nerve Neoplasm C1263898
oncology
17q11 2 Microduplication Syndrome C3495679
genetic
Different category
Bottom line
abducens-nerve-neoplasm-C1263898 and 17q11-2-microduplication-syndrome-C3495679 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abducens Nerve Neoplasm C1263898 | 17q11 2 Microduplication Syndrome C3495679 | Discriminating power |
|---|---|---|---|
| Eye movement | May impair abduction and cause double vision when the sixth nerve is involved. | Eye-movement palsy is not described as a defining feature. | High |
| Development | Developmental delay is not the primary presentation in the source. | Developmental delay and behavioral concerns may occur. | High |
| Onset context | Onset is variable and may follow recognition of a focal neurologic lesion. | Described as congenital, but exact timing is not established here. | Moderate |
When to favor each condition
Choose Abducens Nerve Neoplasm C1263898 when
Progressive diplopia with impaired eye abduction
This pattern warrants evaluation for a sixth-nerve lesion, including neoplasm.
Moderate
Imaging suggests a mass along the abducens nerve
A localized neurologic tumor fits the oncology category rather than a chromosomal syndrome.
High
Symptoms arise without features of a congenital syndrome
Variable onset is more consistent with the nerve-neoplasm description.
Low
Choose 17q11 2 Microduplication Syndrome C3495679 when
Early developmental or behavioral concerns with possible physical features
This pattern better fits a genetic syndrome than an isolated cranial-nerve tumor.
Moderate
Testing shows duplication at 17q11.2
A confirmed duplication supports the genetic condition; imaging alone does not.
High
Care planning centers on developmental support
The stated focus is early intervention rather than tumor-directed therapy.
Moderate
How key tests differ
| Test | Abducens Nerve Neoplasm C1263898 | 17q11 2 Microduplication Syndrome C3495679 | Interpretation |
|---|---|---|---|
| MRI of brain and orbits | May show a lesion involving the abducens nerve; imaging is not a complete diagnosis. | Not expected to establish a chromosomal microduplication. | Use imaging for focal nerve pathology and genetics for the syndrome. |
| Chromosomal microarray | Not the primary test for an isolated nerve tumor. | May detect a 17q11.2 duplication when clinically indicated. | A positive result needs clinician interpretation and does not assess tumor behavior. |
| Neuro-ophthalmic examination | May document an abduction deficit or diplopia. | Eye findings are not established; developmental assessment is more relevant. | Ocular findings help localize nerve dysfunction but do not exclude another condition. |
Prognosis comparison
Abducens Nerve Neoplasm C1263898
- Outcome
- Outcome is not established here and depends on tumor extent and response to care.
- Factors
- Location, growth, neurologic deficit, and treatment effects.
17q11 2 Microduplication Syndrome C3495679
- Outcome
- Long-term outcome is not established; needs often relate to development and behavior.
- Factors
- Developmental impact, associated features, and access to early support.
Time frame: Both are described as chronic, but no specific timeline is established.
Etiology, severity, age at recognition, and confirmed findings should guide counseling.
Complications comparison
| Complication | Presentation |
|---|---|
| Visual function | Persistent diplopia or reduced binocular vision may occur. Vision-specific complications are not established in the source. Do not assume shared ocular risk without supporting findings. |
| Neurologic course | Tumor growth or treatment may affect nearby cranial structures. Tumor-related neurologic complications are not described. Listed severity differs, but individual course is not established here. |
| Development and behavior | Not described as a primary developmental syndrome. Delays and behavioral concerns may require ongoing support. Early intervention is the stated management focus for the syndrome. |
Patient education highlights
- HighSeparate conditions
A cranial-nerve tumor and a congenital chromosomal duplication are different diagnoses and should not be inferred from each other.
- HighMeaning of tests
An imaging abnormality or genetic result requires specialist interpretation and is not automatically a complete diagnosis.
- MediumCare planning
Tumor care may involve surgery or radiation decisions; syndrome care emphasizes individualized developmental support.